最后更新: 八月 27, 2026
How Are Stem Cells Administered for Hearing Loss?
In cases of hearing loss associated with inner-ear dysfunction, previous infection, 创伤, 炎, or certain genetic disorders, mesenchymal stromal cell therapy is being investigated as a regenerative approach. The method of administration must always be selected individually after determining the precise cause and location of the hearing impairment.
The inner ear is a small, delicate, and anatomically difficult-to-access organ. Direct local injection into or near its structures is an invasive procedure that may damage residual hearing, the cochlea, the vestibular apparatus, or adjacent neural structures. 为此原因, systemic intravenous administration may be considered as a less invasive method of introducing cells into the circulation.
The organs and tissues of the human body are interconnected through the vascular system and microcirculation. Following intravenous administration, the cells enter the bloodstream and interact with biological signals produced by injured, inflamed, or stressed tissues. These signals may include chemokines, 细胞因子, 粘附分子, 和生长因子.
Mesenchymal stromal cells carry receptors capable of responding to some of these molecular signals. 这个过程被称为 细胞归巢 或者 趋化性. 相当, molecular gradients may influence their adhesion, 迁移, and biological activity. research has identified signalling pathways such as SDF-1/CXCR4 as potentially relevant to cell migration toward injured cochlear tissues.
The possible therapeutic action is thought to depend mainly on paracrine signalling. Mesenchymal stromal cells release biologically active factors that may:
- modulate excessive inflammation;
- influence immune-cell activity;
- reduce cellular stress;
- support microvascular and endothelial function;
- stimulate survival and repair mechanisms in resident cells;
- promote a tissue environment more favourable to regeneration.
Depending on the underlying pathology, the affected structures may include cochlear hair cells, supporting cells, the stria vascularis, auditory neurons, the auditory nerve, or the inner-ear microcirculation. The potential cellular response may therefore differ considerably between hearing loss caused by inflammation or trauma and hearing loss resulting from an irreversible genetic defect.
Only very small numbers of endogenous progenitor cells normally circulate in peripheral blood, and their natural activity may be insufficient to reverse established chronic damage. In cell-therapy protocols, cells may therefore be isolated and expanded under controlled laboratory conditions to obtain a clinically defined dose. This process can take approximately seven days, 取决于细胞的来源, the manufacturing protocol, and the required quality-control testing.
An intravenous dose—for example, 10 million or more cells
科学案例回顾
您想了解当前的临床项目是否, 最近的研究进展, 或者新兴的方法可能是 与您的个人情况相关?
与我们的科研团队分享您的问题并接收 重点关注当前研究领域的信息，这些领域可能是 与您的案例相关.
- 审查您提供的信息
- 相关研究和临床项目信息
- 针对您的情况做出明确的回应
无义务. 您的问题将得到保密审查.
仅教育和研究信息. 这项服务不 构成医疗建议, 诊断, 处方, 或个性化的 治疗建议.
